180 related articles for article (PubMed ID: 31629575)
1. Symptoms of Secondary Hyperparathyroidism in Patients Receiving Maintenance Hemodialysis: A Prospective Cohort Study.
Levy AR; Xing S; Brunelli SM; Cooper K; Finkelstein FO; Germain MJ; Kimel M; Platt RW; Belozeroff V
Am J Kidney Dis; 2020 Mar; 75(3):373-383. PubMed ID: 31629575
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
Block GA; Bushinsky DA; Cheng S; Cunningham J; Dehmel B; Drueke TB; Ketteler M; Kewalramani R; Martin KJ; Moe SM; Patel UD; Silver J; Sun Y; Wang H; Chertow GM
JAMA; 2017 Jan; 317(2):156-164. PubMed ID: 28097356
[TBL] [Abstract][Full Text] [Related]
4. Self-reported symptoms in patients on hemodialysis with moderate to severe secondary hyperparathyroidism receiving combined therapy with cinacalcet and low-dose vitamin D sterols.
Chertow GM; Lu ZJ; Xu X; Knight TG; Goodman WG; Bushinsky DA; Block GA
Hemodial Int; 2012 Apr; 16(2):188-97. PubMed ID: 22118402
[TBL] [Abstract][Full Text] [Related]
5. 7-84 parathyroid hormone fragments are proportionally increased with the severity of uremic hyperparathyroidism.
Chang JM; Lin SP; Kuo HT; Tsai JC; Tomino Y; Lai YH; Chen HC
Clin Nephrol; 2005 May; 63(5):351-5. PubMed ID: 15909594
[TBL] [Abstract][Full Text] [Related]
6. Mental Effects of Excess Parathyroid Hormone in Hemodialysis Patients: A Possible Role for Parathyroid 2 Hormone Receptor?
Diskin J; Diskin CJ
Ther Apher Dial; 2020 Jun; 24(3):285-289. PubMed ID: 31423747
[TBL] [Abstract][Full Text] [Related]
7. Relationship between the weight of parathyroid glands and their secretion of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism.
Kakuta T; Tanaka R; Kanai G; Miyamoto Y; Inagaki M; Suzuki H; Fukagawa M; Saito A
Ther Apher Dial; 2008 Oct; 12(5):385-90. PubMed ID: 18937722
[TBL] [Abstract][Full Text] [Related]
8. Effect of vitamin C on parathyroid hormone in hemodialysis patients with mild to moderate secondary hyperparathyroidism.
Sanadgol H; Bayani M; Mohammadi M; Bayani B; Mashhadi MA
Iran J Kidney Dis; 2011 Nov; 5(6):410-5. PubMed ID: 22057074
[TBL] [Abstract][Full Text] [Related]
9. Two Years of Cinacalcet Hydrochloride Treatment Decreased Parathyroid Gland Volume and Serum Parathyroid Hormone Level in Hemodialysis Patients With Advanced Secondary Hyperparathyroidism.
Yamada S; Tokumoto M; Taniguchi M; Toyonaga J; Suehiro T; Eriguchi R; Fujimi S; Ooboshi H; Kitazono T; Tsuruya K
Ther Apher Dial; 2015 Aug; 19(4):367-77. PubMed ID: 25851690
[TBL] [Abstract][Full Text] [Related]
10. Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism.
Sprague SM; Wetmore JB; Gurevich K; Da Roza G; Buerkert J; Reiner M; Goodman W; Cooper K
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1021-30. PubMed ID: 25873267
[TBL] [Abstract][Full Text] [Related]
11. A Randomized Trial of Cinacalcet versus Vitamin D Analogs as Monotherapy in Secondary Hyperparathyroidism (PARADIGM).
Wetmore JB; Gurevich K; Sprague S; Da Roza G; Buerkert J; Reiner M; Goodman W; Cooper K
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1031-40. PubMed ID: 25904755
[TBL] [Abstract][Full Text] [Related]
12. Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.
Fukagawa M; Kido R; Komaba H; Onishi Y; Yamaguchi T; Hasegawa T; Kurita N; Fukuma S; Akizawa T; Fukuhara S
Am J Kidney Dis; 2014 Jun; 63(6):979-87. PubMed ID: 24119541
[TBL] [Abstract][Full Text] [Related]
13. Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients.
Rauscher S; Lafrance JP; Pichette V; Bell RZ; Desforges K; Lepage L; Ouellet G; Ouimet D; Leblanc M; Lamarche C; Bezzaoucha S; Vallee M
Int Urol Nephrol; 2017 Feb; 49(2):325-328. PubMed ID: 27822674
[TBL] [Abstract][Full Text] [Related]
14. Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials.
Block GA; Bushinsky DA; Cunningham J; Drueke TB; Ketteler M; Kewalramani R; Martin KJ; Mix TC; Moe SM; Patel UD; Silver J; Spiegel DM; Sterling L; Walsh L; Chertow GM
JAMA; 2017 Jan; 317(2):146-155. PubMed ID: 28097355
[TBL] [Abstract][Full Text] [Related]
15. [Early risk factors for secondary hyperparathyroidism in hemodialysis patients].
Petrauskiene V; Bumblyte IA; Kuzminskis V; Sepetauskiene E
Medicina (Kaunas); 2005; 41 Suppl 1():44-9. PubMed ID: 15901975
[TBL] [Abstract][Full Text] [Related]
16. [Secondary hyperparathyroidism: incidence, clinical presentations, treatment].
Samokhvalova NA; Romanchishen AF; Gerasimchuk RP; Grinev KM; Zemchenkov AIu
Vestn Khir Im I I Grek; 2007; 166(5):78-81. PubMed ID: 18154100
[TBL] [Abstract][Full Text] [Related]
17. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.
Tentori F; Wang M; Bieber BA; Karaboyas A; Li Y; Jacobson SH; Andreucci VE; Fukagawa M; Frimat L; Mendelssohn DC; Port FK; Pisoni RL; Robinson BM
Clin J Am Soc Nephrol; 2015 Jan; 10(1):98-109. PubMed ID: 25516917
[TBL] [Abstract][Full Text] [Related]
18. Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L.
Yamada S; Ueki K; Tokumoto M; Suehiro T; Kimura H; Taniguchi M; Fujimi S; Kitazono T; Tsuruya K
Ther Apher Dial; 2016 Feb; 20(1):31-9. PubMed ID: 26482334
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of intravenous alfacalcidol in the treatment of secondary hyperparathyroidism in patients on hemodialysis.
González MT; Torregrosa JV; Colomé E; Mendia A; Pavesi M
Nephron Clin Pract; 2008; 108(2):c141-7. PubMed ID: 18259100
[TBL] [Abstract][Full Text] [Related]
20. Secondary hyperparathyroidism in patients on maintenance hemodialysis.
Hida M
Tokai J Exp Clin Med; 1982 Nov; 7(6):665-70. PubMed ID: 7184198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
